13F Pro

SEC Form 4 reporting owner

Ticho Barry

Ticho Barry has filed 24 Form 4 transactions reported between February 17, 2026 and September 1, 2026, as CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc..

Name as filed: Ticho Barry

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.4M
17 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 1, 2026
transaction date

Roles and reported holdings

  • STOKStoke Therapeutics, Inc.
    Feb 17, 2026 – Sep 1, 2026

    CHIEF MEDICAL OFFICER

    Held directly20,110 sh as of Sep 1, 2026 · Form 4

    24 months: $1.4M sold

Transaction history

All 24 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 1, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,600$50K@ $31.06Form 4
Sep 1, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct3,945$120K@ $30.51Form 4
Aug 18, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct242$8K@ $32.47Form 4
Aug 18, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct4,525$145K@ $32.01Form 4
Aug 14, 2026STOKCHIEF MEDICAL OFFICEROption exerciseCode M · direct10,000—Form 4
Aug 3, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,269$37K@ $29.45Form 4
Aug 3, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct5,907$171K@ $28.95Form 4
Jul 1, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct500$17K@ $33.27Form 4
Jul 1, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct6,728$219K@ $32.62Form 4
Jun 1, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,795$55K@ $30.58Form 4
May 1, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,243$74K@ $32.79Form 4
Apr 1, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,838$60K@ $32.66Form 4
Mar 19, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,461$44K@ $29.99Form 4
Mar 19, 2026STOKCHIEF MEDICAL OFFICEROption exerciseCode M · direct1,365$3K@ $2.19Form 4
Mar 18, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct103$3K@ $32.85Form 4
Mar 18, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct483$15K@ $31.79Form 4
Mar 18, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct6,100$191K@ $31.28Form 4
Mar 17, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,587$86K@ $33.38Form 4
Mar 17, 2026STOKCHIEF MEDICAL OFFICEROpen-market saleCode S · direct3,577$117K@ $32.74Form 4
Mar 15, 2026STOKCHIEF MEDICAL OFFICEROption exerciseCode M · direct10,750—Form 4
Mar 15, 2026STOKCHIEF MEDICAL OFFICEROption exerciseCode M · direct10,000—Form 4
Mar 15, 2026STOKCHIEF MEDICAL OFFICEROption exerciseCode M · direct13,100—Form 4
Feb 17, 2026STOKCHIEF MEDICAL OFFICERGrant or awardCode A · direct40,000—Form 4
Feb 17, 2026STOKCHIEF MEDICAL OFFICERGrant or awardCode A · direct60,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.